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1. Introduction 
N-acetyl aspartic (Acetyl-Asp) is present in m~rn~ian 
brain tissue at a concentration of 5-6 /..moles/g fresh 
tissue weight [ 1,2] . The compound was previously 
considered to be metabolic~ly inert [l] , and has a very 
slow turnover in cortex slices in vitro [3 ] and in vivo 
[4] . A rapid sequestration of Acetyl-Asp into an alkali- 
labile compound on addition of mono-, di-, or poly 
amines to tissue slices of brain [ 51, and stoichiometric 
with the added amine, su~ested that Acetyl-Asp could 
take part in a cyclic process without being metabolized. 
Blocking monoamine oxidase (EC 1.4.3.4) in homoge- 
nates of mouse brain incubated in the presence of amino 
acids (1 mM), an ATP-regenerating system and histamine, 
led to the fo~ation of numerous ~-ace~l-aspa~yl 
peptides [6]. These were formed de novo as judged by 
isdtope incorporation from l4 C-labelled and recoverable 
precursors, and probably independently of protein 
synthesis as the formation was not affected by inhibitors 
of the protein synthesizing machinery of the tissue 161. 
We wish to report that a certain degree of specificity of 
peptide synthesis, dependent on the amine added, is 
discernable inhomogenates of monkey cortex, and that 
the pattern of peptides formed is regulated to a large 
extent by the amino acids present in concentrations 
above 0.5 mM in the homogenate. 
2. Materials and methods 
Brains of Cercopithecus ethiops were obtained and 
stored at -90°C as described previously [71. The frozen 
cortical tissue was forcibly cut into thin flakes and 
homogenized for 20 set at 715 rpm in a Potter Elvehjem 
North-HoIland Publishing Company - Amsterdam 
Teflon homogen~er with all-round clearance of 0.01 
cm in 4 vol of ice-cold phosphate buffer [ 81 containing 
4 mM Nialamide. 
Incubation was performed for 30 min as described 
[6] with an ATP-regenerating system. Final concen- 
trations in the incubation medium were K-phosphate 
25 mM, pH 7.4, MgClz 10 mM, Glucose 10 mM, Na- 
phosphate 5mM, pH 7.4, KCl 50 mM, ATP 0.5 mM, 
phosphoenolpyruvate 0.25 mM and pyruvate kinase 
(EC 2.7.1.40 from rabbit muscle) 20 clg/ml. The 
concentration of each amino acid added was 0.5 mM 
and of monoamines 0.5 to 1 mM. The reaction was 
stopped with perchloric acid to 0.1 M at 0°C and the 
perchloric acid removed as K-perchlorate by neutrali- 
sation with KOH to pH 6.5. 
The amino acids and peptides with free N-terminal 
amine groups were removed by cation exchange on 
Dowex 50 X 2 (ZOO-400 mesh, 1 X 10 cm) in the g 
form, The N-substituted amino acids and peptides were 
separated by anion exchange as described in fig. 1 
and ref. [6]. Individu~ peaks were lyophilized and 
passed through a Bio-Gel P 2 column (BIORAD Labs: 
100-200 mesh with exclusion limit 1600 daltons) of 
dimensions 1.6 X 90 cm in 0.2 M formic acid at a 
flow rate of 2 ml/IO min. Further purification was 
carried out by chromatography on washed Whatman 
3 MM paper [7] and silica gel plates in n-butanollacetic 
acid/water (120: 30: 50; by vol) and phenol/water 
(250:62,5; weight: volume). Complete hydrolysis was 
performed in 6 M glass-distilled HCl at 110°C for 16 hr 
[6], the HCl removed under vacuum over KOH, and 
the residue analyzed on a commercial amino acid 
analyzer [6 J . Partial fractionation and cleavage of 
especially the labile aspartylpeptide bond was perform- 
ed in 0.1 M HCl for 1 hr at 11 O”C, followed by anion 
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exchange as described in fig. 1, thin-layer chromato- 
graphy and complete hydrolysis of the fragments. When 
a constant amino acid composition was obtained, despite 
further purification with concommitant loss of material, 
the peptides were considered tentatively pure. ’ 4 C-label- 
led Acetyl-Asp (specific activity 71 200 cpm/pmol) 
was prepared as described [6] and incorporation measur- 
ed in Asp and or Acetyl-Asp recovered from the peptides 
after hydrolysis [6]. 
3. Results 
Fig. 1 illustrates the pattern of N-substituted com- 
pounds obtained with either Noradrenaline or 
Dopamine in the presence of 0.5 mM Acetyl-Asp, Glu, 
GABA and Cys added to cortical homogenates. In the 
absence of an ATP-regenerating system or monoamine 
no peptides were formed in monkey and mouse cortex 
[6]. Peak C has previously been shown to be pyroglu- 
tamic acid [6,7] . The peak appearing at 220-250 ml 
(fig. 1) is a complex peak consisting of cysteine and 
taurine-containing peptides. Peak A and B moved as 
single peaks on gel filtration on P2 with the major 
component of each eluting earlier than free amino 
acids and amines. Peak A had an apparent K,, of 0.49, 
B of 0.5 1, while Acetyl-Asp had a K, of 0.78. On 
thin-layer chromatography both A and B moved as 
one spot as determined by the labelling from the 
Acetyl-Asp which was then recovered by hydrolysis 
in 0.1 M HCl for 1 hr, together with Asp and other 
peptide fragments (table 1). The total amino acid 
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Fig. 1. The amino acids and peptides with a free amino terminal group except Tau, were removed by cation exchange at pH 6.2 
as described in methods. After freeze drying, dissolving in 3 ml H, 0 and neutralizing to pH 6.5, the N-substituted compounds 
were applied on to a Dowex 1 X 4 (200-400 mesh) column in the formate form of dimensions 1 X 20 cm, and eluted with 
a formic acid gradient of water to 2 M formic acid (200: 200 ml by vol) at a rate of 2 ml fractions/lo min [ 71. The N-substituted 
compounds were split by hydrolysis of 0.4 ml aliquots of each 2 ml fraction in 2 M KOH for 2 hr [6], neutralized by HCI and 
reacted with ninhydrin using Rosen’s technique [9]. Without hydrolysis only Tau, eluting at lo-20 ml was coloured. A log I/I,, at 
570 nm of 0.210 is equivalent to 0.05 Mmoles of amino acid. -is the curve obtained with 0.5 mM Noradrenalin, and -o--a-* 
-. the curve for 0.5 mM Dopamine with Acetyl-Asp, GABA, Glu and Cys (1 mM) added to the incubation mixture. Log 
(I/1,)57 0 nm range in 3 experiments for peak A was 0.250-0.400. 
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Table 1 
From Elution 
fig. vol (ml) 
Composition n 0.1 M HCI Probable mmol/mol Isolation K,, Rf 
sequence fragments structure AC-ASP 
in 30 min 
A (50-60) 1 0.49 0.13 Asp’,Gly, 
CYS 
B (67-75)* 1 0.51 0.31 Asp,Glu 
Ser, Gly 
2 43-55 
2 155-164* 
2 155-164* 
1 0.32 0.76 Asp, Se?, 
Glu’ , Gly’ , 
Ala 
1 and 2 0.32 0.15 Asp, Glu, 
Gly’ , Cys’ , 
Tau 
1 and 2 0.55 0.65 Asp, Glu 
2 160-180* 
2 160-180* 
1 and 2 0.50 0.54 Asp’, Glu 
1 and 2 0.35 0.59 Asp4, Ser, 
Gly , Glu 
3 AC-ASP 
3 AC-ASP, 
AC-Asp-Glu, 
Glu-Ser 
4 AC-ASP, 
AC-Asp-Glu 
5 AC-ASP, 
AC-Asp-Glu 
10 AC-ASP, 
Asp-Glu 
5 AC-ASP, 
AC-ASP -Glu 
4 AC-ASP-ASP 
AC-ASP (Asx’ , 
Cys, Gly) 
Ac-Asp-Glu- 
Se-Gly 
AC-ASP -Glu 
(Se?, Glu, 
Gly’ , Ala) 
AC-Asp-Glu 
(Gly’, Cyst) 
Tau 
AC-Asp-Glu 
Ac-Asp-Glu- 
Asp 
AC-ASP-ASP 
(Asx’ , Glu, 
Gly, Ser) 
n.d. 
n.d. 
n.d. 
54-110 
n’ = 3 
67-99 
n’ = 4 
n.d. 
n.d. 
Fractions were pooled and corresponding fractions from 5-10 experiments added together. Purification sequence 1 involves the 
following: Dowex 50 - Dowex 1 - P 2 - paper - TLC X 2; and sequence 2: Dowex 50 - Dowex 1 - paper - P 2 - TLC X 2 
(see Matherials and methods). Rfvalues are given for paper chromatography in n-Butanollacetic acid/water. Kav = Ve-Vg X 
l/V,-VO. n is number of amino acid analyses after hydrolysis. The more important fragments from 0.1 M HCl, 1 hr, 110 C hydro- 
lysis and anion exchange on Dowex 1 (as in fig. 1) are shown. Incorporation is calculated from specific activity of “C-labelled 
Acetyl-Asp (AC-ASP in table) found in Asp or Acetyl-Asp following 0.1 M hydrolysis [6]. Asp, Acetyl-Asp and Glu have Kav = 0.78. 
* The compound has been reported in mouse brain [6]. n.d. not determined. 
composition of the purified peptides is shown in 
table 1, where the range of incorporation of Acetyl- 
Asp is also given. 
Fig. 2 demonstrates the pattern obtained with 
histamine (0.5 mM) and the amino acids added as in 
fig. 1. If however, histamine is incubated in the 
cortical homogenates with Acetyl-Asp, Glu, Gly, Ala, 
Tau, GluNH2, Cys and Ser added (0.5 mM), a complex 
elution pattern with numerous peptidic peaks is demon- 
strable (fig. 2). The compositions of a few of these 
peptides are shown in table 1. K, values for gel fil- 
tration on P2 gel are given in a separate column, and 
are clearly closer to the void volume than free amino 
acids. It should be noted that several of the peptidic 
constituents are transmitter candidates, or have effects 
on membrane potentials, such as Asp, Glu, Gly, Tau, 
Cys and Ala. 
4. Discussion 
The compounds are peptides as they are separable 
from the constituent free amino acids by ion-exchange, 
gel fdtration, paper and thin-layer chromatography. 
These peptidic compounds are furthermore N-substitut- 
ed as all free amino acids except Tau are retained on a 
Dowex 50 column in the I-l+ form at pH 6.5, and also 
Acetyl-Asp could be recovered from the compounds 
on partial hydrolysis. Furthermore the compounds were 
were ninhydrin positive only after hydrolysis (fig. 1). 
The bonding must be covalent in order to survive the 
sequence of isolation which exposes the compounds to 
low pH, and, during elution from the thin-layer chroma- 
tograms, to low ionic strength [lo] . The compounds 
are also probably formed de novo as they incorporate 
r4C-labelled Acetyl-Asp and also other l4 C-labelled 
amino acids (to be published). The simple molar ratio 
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Fig. 2. Anion exchange on Dowex 1 of the N-substituted peptides and amino acids, formed with the amine histamine (0.5 mM) 
present. For (e-e-@-*) the amino acids Acetyl-Asp, Glu, GABA and Cys (1.0 mM) were used. ( p) Demonstrates the vastly 
more complex pattern obtained when Acetyl-Asp, Glu, Gly, Ala, Tau, Gln, Cys and Ser (1 mM) were added to the incubation 
mixture. Without prior hydrolysis in alkali, no ninhydrin colour was formed except at lo-20 ml (Tau). 
of the constituent amino acids, which remains constant 
in spite of further purification with loss of material, 
suggests that the peptides probably are pure. One of 
the peptides, Acetyl-Asp-Glu is found preformed in 
brain [4] , and the isolated peptide behaved as 
synthetic standards. 
The function of the peptides, formed in cortical 
homogenates is unknown. It may be relevant that 
the hypothalamic releasing factors, contained in vesi- 
cles (granula) of the median eminence [ 1 l] are also 
peptides [ 121, and that the hypothalamus contains 
high endogenous levels of monoamines [ 131. Mono- 
amines are also associated with polypeptide hormones 
and propeptides in the storage granula in endocrine 
cells [ 141. The peptide synthesis reported here, 
previously shown to be probably independent of pro- 
tein synthesis [6] , is apparently largely determined by 
the amine present, as well as the amino acids added at 
concentrations above 0.5 mM in the medium. Data from 
a more purified enzyme complex supports this view (to 
be published). 
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